Draft:Acne Awareness Month

Global Acne Markets, Epidemiology and Patient Flow Report 2020-2035 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 11, 2021
General Health, Pharmaceutical, Health, Acneiform eruptions, Organ systems, Acne, Puberty, Draft:Acne Awareness Month

b'The "Global Acne Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Acne Epidemiology and Patient Flow Analysis - 2021, provides Acne epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Acne Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Acne Epidemiology and Patient Flow Analysis - 2021, provides Acne epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Acne patients, history of the disease at the population level (Acne prevalence, Acne incidence) and at the clinical level (from diagnosis to treated patients).\nIt also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Acne patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Acne market sizing, assessing market potential, and developing drug forecast models\nIdentify Acne patients segments through age groups, gender, and disease sub-types\n'

DERMALA Announces $6.73 Million Series A Financing to Expand and Scale Company’s Personalized Microbiome-Based Solutions for Acne and Other Skin Conditions

Retrieved on: 
Monday, November 9, 2020
Children, Biotechnology, Alternative medicine, Other Health, Health, General Health, Women, MEN, Family, Consumer, Teens, Acneiform eruptions, Organ systems, Medical specialties, Acne, Puberty, Dermatology, Dermatitis, Skin care, Draft:Acne Awareness Month, Yoram Harth

DERMALA, Inc., a consumer dermatology company developing novel, personalized, microbiome-based solutions for acne and other skin conditions, announced today that it has closed a $6.73 million Series A financing.

Key Points: 
  • DERMALA, Inc., a consumer dermatology company developing novel, personalized, microbiome-based solutions for acne and other skin conditions, announced today that it has closed a $6.73 million Series A financing.
  • The consumer dermatology category is ripe for science-based solutions to treat common skin conditions, said Lada Rasochova, Ph.D., MBA, Founder and CEO of DERMALA.
  • The solution comprises topical acne treatments and oral supplements paired with the DERMALA Acne Tracker app, which customers use to track their skin health.
  • It will also expand its research and development activities exploring new personalized microbiome-based products for other skin conditions including eczema and skin wellness.

How to Treat Acne in Skin of Color; American Academy of Dermatology

Retrieved on: 
Thursday, September 10, 2020
Organ systems, Acneiform eruptions, Dermatology, Integumentary system, Puberty, RTT, Acne, Skin care, Scar, Acne mechanica, Draft:Acne Awareness Month

For these reasons, its critical to treat acne in skin of color carefully and avoid skin care products that can exacerbate discoloration.

Key Points: 
  • For these reasons, its critical to treat acne in skin of color carefully and avoid skin care products that can exacerbate discoloration.
  • To treat acne in skin of color, Dr. Aguh recommends the following tips:
    Keep your hands off.
  • If you have acne, avoid picking, squeezing, and popping your acne, as this can lead to scarring.
  • These tips are demonstrated in How to Treat Acne in Skin of Color , a video posted to the AAD website and YouTube channel .